Toggle navigation
Home
Search
Services
Blog
Contact
About
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P.
Stanford University, Stanford, CA, United States
Search 8 grants from Peggy Lu
Search grants from Stanford University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Vascular Dysfunction with Increased Pulmonary Blood Flow: A role for PPAR Gamma
CAMP Continuation Study Phase 2 (CAMPCS / 2)
D5 receptor antioxidant activity and hypertension
Mechanism of DNA Recombination and Repair in Yeast Saccharomyces Cerevisiae
Recently added grants:
Molecular Structure Determination by Mass Spectrometry and Computational Modeling
Novel synthetic analogue of microbial metabolite, Urolithin A, mitigates inflammatory bowel diseases
Pathogenesis of Yersinia pestis infection during intracellular infection
Modulation of respiratory melioidosis inflammation
Core A: Administrative Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA009324-02
Application #
2085280
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1994-01-01
Project End
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Related projects
NIH 1994
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
NIH 1992
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
Publications
Lu, P H; Negrin, R S
(1994)
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
J Immunol 153:1687-96
Comments
Be the first to comment on this grant